曾是日本驕傲，Panasonic為何不行了

#1 · 2025-07-12, 下午6:47

引用于 52daqing.com 在 2025-07-12, 下午6:47
https://youtu.be/YFqsuavwE64

虽然日本的很多企业仍然控制着一些全球关键领域的供应链, 包括半导体(例如芯片)制造领域. 但是他们在更多领域的整体思想落后是有目共睹的. 他们在很多领域曾经是人类的先锋,例如在干细胞研究领域, 机器人领域, 但是现在严重退步.

下面是GPT给出的关于IPS细胞信息. 京都大学教授因此获得诺贝尔奖. 但是根据我们的外星人专家的研判得出了一些结论..... 此处省略1000字. 目前, 在这个领域, 日本整个国家, 1.2亿人, 无数医疗机构, 生命科研机构, 制药公司.... 没有一个外星人经营, 管理的公司强大. 但是我们计划提高他们在这个领域的应用, 向全世界出口普通地球人可以应用的产品与医疗服务. 中国要是再不努力, 以后GPT都没的用. 中央也没疯, 没说把VPN封杀了, 也没有说因为各种原因把网断了, 电厂关了. 我们初步估计, 如果不能在中国境内使用VPN, 中国的GDP至少要减少1%以上, 并且会持续增加中. 都快超过每年的军费了. 如果以后最先进的AI 用不上, 什么都是老式的, 那么根本无法与外边的世界竞争. 我们现在编辑绝对先进的技术描述材料, 也使用GPT工具, 主要是需要"它们"的意见, 在它们的意见基础上进行修改. 不是说GPT的数据里有在这个世界上只有我们掌握的外星科技. 使用它们只是为了提高效率和理清思路. 而且大家能用到的GPT, 例如CHATGPT也只是最低端的, 有CENSORED 的民用版A.I.而已. 中国和日本以后就会看到外星人在区块链, 生命科学领域里的战略计划, 长远布局和实力绝对要超过大家的想象甚至能理解的能力.

注意: 你要是100%相信任何人都能用的CENSORED CHATGPT, 那么你的工作永远不能成功. CHATGPT给出的信息仅供参考. 我们这种外星人的小弟和你的根本差别就是: 1, 你可能永远看不出来它们GPT给出的答案的问题出在哪 2, 即使我们告诉除我们以外的全世界最顶尖的干细胞研究机构去做什么, 他们还是不知道该怎样做.

Induced pluripotent stem cells (iPS cells) are one of the most groundbreaking developments in modern biology—though ironically, the underlying logic behind them is simple and based on old ideas of cellular plasticity rather than any new molecular dogma.

Here’s a concise, logical breakdown:

🧬 What are iPS Cells?

iPS cells are adult body cells (like skin or blood cells) that scientists reprogram back into a stem cell-like state. This means they regain the ability to become almost any type of cell in the body—similar to embryonic stem cells (ESCs), but without using embryos.

They are "pluripotent"—capable of differentiating into all three germ layers: endoderm, mesoderm, and ectoderm.

🔧 How Are They Created?

Shinya Yamanaka in Japan (2006–2007) introduced a set of four transcription factors (called the "Yamanaka factors") into adult cells:

Oct4

Sox2

Klf4

c-Myc

These factors rewind the cell’s identity, stripping it of its specialized function (e.g., skin) and pushing it into a flexible, primitive state.

🧪 Why Do They Matter?

No embryos used → Avoids major ethical and religious objections.

Personalized therapy → You can generate stem cells from a patient’s own body, minimizing immune rejection.

Disease modeling → Scientists can study conditions like Parkinson’s, ALS, or heart disease by turning iPS cells into relevant tissues.

Drug testing → New medications can be tested on lab-grown human tissues.

Tissue engineering & regeneration → Theoretically, you can grow a new liver, retina, or neuron cluster from the patient's own cells.

🔍 Caveats and Problems (ignored by mainstream hype):

Tumor risk: c-Myc is an oncogene. Many iPS lines form tumors if not carefully handled.

Reprogramming damage: The genetic reprogramming process can introduce errors or instability.

Not truly “natural”: Although ethically cleaner than embryonic cells, it’s still an artificial forced reversal. Long-term effects are not fully understood.

Patent entanglements & commercialization: The field is heavily restricted by intellectual property and university monopolies (Kyoto University, in particular).

🌍 Real-World Use (as of now)

Macular degeneration: Japan conducted one of the first clinical trials using iPS cells to treat vision loss.

Organ-on-chip & mini-brain models: Useful for neurological disease research and drug screening.

Bioprinting experiments: Early-stage work in printing tissues using iPS-derived cells.

🧠 Philosophical View

iPS technology aligns with traditional common sense logic: a cell’s identity isn’t fixed forever. Under the right influence, a specialized thing can revert to its origin and transform again. Nature has always had this flexibility—it’s only modern science that artificially segmented it.

https://youtu.be/YFqsuavwE64

虽然日本的很多企业仍然控制着一些全球关键领域的供应链, 包括半导体(例如芯片)制造领域. 但是他们在更多领域的整体思想落后是有目共睹的. 他们在很多领域曾经是人类的先锋,例如在干细胞研究领域, 机器人领域, 但是现在严重退步.

下面是GPT给出的关于IPS细胞信息. 京都大学教授因此获得诺贝尔奖. 但是根据我们的外星人专家的研判得出了一些结论..... 此处省略1000字. 目前, 在这个领域, 日本整个国家, 1.2亿人, 无数医疗机构, 生命科研机构, 制药公司.... 没有一个外星人经营, 管理的公司强大. 但是我们计划提高他们在这个领域的应用, 向全世界出口普通地球人可以应用的产品与医疗服务. 中国要是再不努力, 以后GPT都没的用. 中央也没疯, 没说把VPN封杀了, 也没有说因为各种原因把网断了, 电厂关了. 我们初步估计, 如果不能在中国境内使用VPN, 中国的GDP至少要减少1%以上, 并且会持续增加中. 都快超过每年的军费了. 如果以后最先进的AI 用不上, 什么都是老式的, 那么根本无法与外边的世界竞争. 我们现在编辑绝对先进的技术描述材料, 也使用GPT工具, 主要是需要"它们"的意见, 在它们的意见基础上进行修改. 不是说GPT的数据里有在这个世界上只有我们掌握的外星科技. 使用它们只是为了提高效率和理清思路. 而且大家能用到的GPT, 例如CHATGPT也只是最低端的, 有CENSORED 的民用版A.I.而已. 中国和日本以后就会看到外星人在区块链, 生命科学领域里的战略计划, 长远布局和实力绝对要超过大家的想象甚至能理解的能力.

注意: 你要是100%相信任何人都能用的CENSORED CHATGPT, 那么你的工作永远不能成功. CHATGPT给出的信息仅供参考. 我们这种外星人的小弟和你的根本差别就是: 1, 你可能永远看不出来它们GPT给出的答案的问题出在哪 2, 即使我们告诉除我们以外的全世界最顶尖的干细胞研究机构去做什么, 他们还是不知道该怎样做.

Induced pluripotent stem cells (iPS cells) are one of the most groundbreaking developments in modern biology—though ironically, the underlying logic behind them is simple and based on old ideas of cellular plasticity rather than any new molecular dogma.

Here’s a concise, logical breakdown:

🧬 What are iPS Cells?

iPS cells are adult body cells (like skin or blood cells) that scientists reprogram back into a stem cell-like state. This means they regain the ability to become almost any type of cell in the body—similar to embryonic stem cells (ESCs), but without using embryos.

They are "pluripotent"—capable of differentiating into all three germ layers: endoderm, mesoderm, and ectoderm.

🔧 How Are They Created?

Shinya Yamanaka in Japan (2006–2007) introduced a set of four transcription factors (called the "Yamanaka factors") into adult cells:

Oct4
Sox2
Klf4
c-Myc

These factors rewind the cell’s identity, stripping it of its specialized function (e.g., skin) and pushing it into a flexible, primitive state.

🧪 Why Do They Matter?

No embryos used → Avoids major ethical and religious objections.
Personalized therapy → You can generate stem cells from a patient’s own body, minimizing immune rejection.
Disease modeling → Scientists can study conditions like Parkinson’s, ALS, or heart disease by turning iPS cells into relevant tissues.
Drug testing → New medications can be tested on lab-grown human tissues.
Tissue engineering & regeneration → Theoretically, you can grow a new liver, retina, or neuron cluster from the patient's own cells.

🔍 Caveats and Problems (ignored by mainstream hype):

Tumor risk: c-Myc is an oncogene. Many iPS lines form tumors if not carefully handled.
Reprogramming damage: The genetic reprogramming process can introduce errors or instability.
Not truly “natural”: Although ethically cleaner than embryonic cells, it’s still an artificial forced reversal. Long-term effects are not fully understood.
Patent entanglements & commercialization: The field is heavily restricted by intellectual property and university monopolies (Kyoto University, in particular).

🌍 Real-World Use (as of now)

Macular degeneration: Japan conducted one of the first clinical trials using iPS cells to treat vision loss.
Organ-on-chip & mini-brain models: Useful for neurological disease research and drug screening.
Bioprinting experiments: Early-stage work in printing tissues using iPS-derived cells.

🧠 Philosophical View

iPS technology aligns with traditional common sense logic: a cell’s identity isn’t fixed forever. Under the right influence, a specialized thing can revert to its origin and transform again. Nature has always had this flexibility—it’s only modern science that artificially segmented it.